share_log

康希諾生物:股份發行人的證券變動月報表

CANSINOBIO: Monthly Return of Equity Issuer on Movements in Securities

HKEX ·  Nov 5 16:39

Summary by Moomoo AI

康希諾生物股份公司於2024年11月5日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年10月31日的公司股份變動情況。報告顯示,康希諾生物的H股(股份代號06185)和A股(股份代號688185)在該月份均無增減,H股和A股的已發行股份數目分別維持在132,670,900股和114,778,999股。此外,公司於2022年1月23日公告的未來員工持股計劃或股權激勵計劃為目的之A股回購方案,截至2024年10月31日,自2022年2月7日至2022年12月1日期間回購的406,098股普通股A股尚未注銷。報告期間內,康希諾生物未進行任何股份的購回或注銷活動。
康希諾生物股份公司於2024年11月5日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年10月31日的公司股份變動情況。報告顯示,康希諾生物的H股(股份代號06185)和A股(股份代號688185)在該月份均無增減,H股和A股的已發行股份數目分別維持在132,670,900股和114,778,999股。此外,公司於2022年1月23日公告的未來員工持股計劃或股權激勵計劃為目的之A股回購方案,截至2024年10月31日,自2022年2月7日至2022年12月1日期間回購的406,098股普通股A股尚未注銷。報告期間內,康希諾生物未進行任何股份的購回或注銷活動。
Cansinobio submitted the latest monthly report on securities changes to the Hong Kong Exchanges and Clearing Limited on November 5, 2024, reporting the company's share changes up to October 31, 2024. The report shows that there were no changes in the H shares (stock code 06185) and A shares (stock code 688185) of Cansinobio in that month, with the issued share capital of H shares and A shares remaining at 132,670,900 shares and 114,778,999 shares respectively. In addition, the A-share repurchase program announced by the company on January 23, 2022, for the purpose of future employee shareholding or stock-based incentive plans, as of October 31, 2024, a total of 406,098 ordinary A shares repurchased between February 7, 2022, and December 1, 2022, have not yet been cancelled. During the reporting period, Cansinobio did not engage in any share repurchases or cancellations.
Cansinobio submitted the latest monthly report on securities changes to the Hong Kong Exchanges and Clearing Limited on November 5, 2024, reporting the company's share changes up to October 31, 2024. The report shows that there were no changes in the H shares (stock code 06185) and A shares (stock code 688185) of Cansinobio in that month, with the issued share capital of H shares and A shares remaining at 132,670,900 shares and 114,778,999 shares respectively. In addition, the A-share repurchase program announced by the company on January 23, 2022, for the purpose of future employee shareholding or stock-based incentive plans, as of October 31, 2024, a total of 406,098 ordinary A shares repurchased between February 7, 2022, and December 1, 2022, have not yet been cancelled. During the reporting period, Cansinobio did not engage in any share repurchases or cancellations.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more